72061223RFA00002: Ana ndi Achinyamata Patsogolo (Children and Youth First) Project
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Malawi USAID-Lilongwe notices from 2023.
Malawi USAID-Lilongwe offered grants of up to $60.0 million (at least $60.0 million) to the applicants described in the notice. It expected to make one award worth $60.0 million in total. Applications closed on July 5, 2023.
From the official notice on Grants.gov, last changed June 15, 2023. Checked November 7, 2026.
- Award ceiling$60.0 million
- Award floor$60.0 million
- Total funding$60.0 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | May 25, 2023 |
|---|---|
| Deadline | July 5, 2023 |
| Archived by Grants.gov | July 22, 2023 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligibility for this NOFO is restricted to local (Malawian) and Regional (Southern African Development Community – SADC) organizations. Applications from organizations that have not previously received financial assistance from USAID are welcome if the Applicant determines that it has necessary capacity to implement projects of the magnitude such as this one. Applicants MUST meet the following criteria that qualifies what a local or regional organization as defined by the President's Emergency Plan for AIDS Relief (PEPFAR). USAID/PEPFAR defines a “local or regional entity” as an individual, a sole Proprietorship, or an entity that: (a) Is incorporated or legally organized under the laws of the country or region and have its principal place of business in the country or region served by the PEPFAR program with which the entity is or may become involved (in this case Malawi or SADC). (b) It is 75% beneficially owned by at the time of the application by individuals who are citizens or lawfully admitted permanent residents of that same country or region.(c) At least 75% of the entity's staff (senior, mid-level, support) at the time of the application must be citizens or lawfully admitted permanent residents of that same country or region and(d) Where an entity has a Board of Directors, at least 51% of the members of the Board must also be citizens or lawfully admitted permanent residents of the country or region.
Is this a realistic fit?
- Past USAID Foreign Assistance for Programs Overseas awards averaged $8.7 million; this notice allows up to $60.0 million per award.
- Most of the program's money (54% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The United States Agency for International Development (USAID) is seeking applications for a Cooperative Agreement from qualified entities to implement the Ana ndi Achinyamata Patsogolo Project. Eligibility for this award is restricted to Malawian and Regional (Southern Africa Development Community - SADC) Applicants. Subject to funding availability and at the discretion of the Agency, USAID intends to provide funding not exceeding $60,000,000.00 over a 5 (five) year period. Eligibility of this award is restricted to Malawian and Regional 9 Sothern Africa Development Community - SADC) Applicants.
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is 72061223RFA00002 still open?
No. It closed on July 5, 2023.
Who can apply for Ana ndi Achinyamata Patsogolo (Children and Youth First) Project?
Malawi USAID-Lilongwe accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Ana ndi Achinyamata Patsogolo (Children and Youth First) Project?
Closed July 5, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $60.0 million each. About $60.0 million in total for one award.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)